glp-1 drugs and alzheimer's Blockbuster Diabetes Weight Loss Fails in Trial GLP-1 and Alzheimer's Disease: Research

Shortly after this, it was demonstrated that GLP-1 suppresses food intake through CNS-mediated mechanisms (Turton et al., 1996

The data available for exenatide showed less of a risk towards thyroid cancer than liraglutide, but to better quantify the risk the FDA has required Amylin to conduct additional rodent studies to better identify the thyroid issue

6 December 2006

Several weeks or months later, the person may notice increased shedding, especially when washing, brushing or styling the hair

Why the hype: Diabetes, obesity, and vascular disease are known contributors to brain aging and dementia risk

Obesity changes your muscle 'engine type': Excess weight shifts muscle fiber composition, reducing efficient, fat-burning Type I fibers and increasing less efficient, fatigue-prone Type IIx fibers, worsening metabolic flexibility